Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

HYDERABAD, India, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV).